# Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

> **NCT01097265** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jeroen Bosch Ziekenhuis** · enrollment: 1500 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **OTHER:** active surveillance
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** lymph node mapping
- **PROCEDURE:** sentinel lymph node biopsy

## Key facts

- **NCT ID:** NCT01097265
- **Lead sponsor:** Jeroen Bosch Ziekenhuis
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097265, "Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01097265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*